Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-20-000567

Director acquired 8,000,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2020-01-22 Conversion : show line 1 in the form +5,000,000 25,683,233 D
2020-01-24 Conversion : show line 2 in the form +3,000,000 28,683,233 D

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2020-01-22 Conversion : show line 3 in the form Series B Convertible Preferred Stock −1,000,000 5,000,000 1,857,143 D
2020-01-24 Conversion : show line 4 in the form Series B Convertible Preferred Stock −600,000 3,000,000 1,257,143 D
Loading xslF345X03/ownership.xml…